By Dr Neil Panchal, co-founder & CMO, Longevitix
One of my patients, a 52-year-old training for her first triathlon, had fourteen months of wearable data on file. Every value sat within normal range.
The AI layer in our platform flagged what a range check would never catch: a slow rise in resting heart rate alongside a decline in HRV, out of pattern for her.
I ordered a thyroid panel. The workup showed subclinical hyperthyroidism, months before symptoms would have brought her in.
I made the diagnosis. The system made sure the pattern reached me in time.
Most of the conversation about AI in medicine is still about replacement.
After a decade in emergency medicine and several years running a longevity practice, I find the better question is what AI does for the physician who uses it well.
More data, less friction
The volume of health data reaching physicians keeps growing, and the barriers around it are coming down.
The EY US Consumer Health Survey found that 55 percent of Americans track their health data. Only 34 percent say their physician has access to it and uses it.
Two developments this year will widen that gap before they close it. Health in ChatGPT rolled out to all US adults, with connections to medical records and wearables.
And in January, the FDA eased its oversight of wellness wearables and AI decision support tools, which lowers the bar for these products to reach patients.
The physician is the one expected to sort what arrives. A panel of two thousand patients generating minute-level data cannot be read by a human. It can be watched by a system that knows each patient’s normal and flags what a physician should see.
Where the help is real
Surveillance between visits comes first. Population reference ranges were built for annual snapshots. Continuous data needs the patient’s own baseline as the standard.
My triathlete’s numbers were unremarkable against a reference chart and abnormal against her own history. Out of pattern matters more than out of range, and AI can hold that baseline for every patient, every day, in a way no clinic staffed by humans can.
Synthesis at the point of care comes second.
A preventive medicine visit now covers wearable trends, lab work, genetics, and whatever the patient read last week. Decision support grounded in curated clinical databases can pull the relevant evidence and the patient’s full history together before the visit, and surface possible interventions for review.
The physician starts the conversation already informed.
Recovered time comes third. Pre-visit summaries, structured intake of outside records, and drafted documentation return hours to medicine.
In my house-call years I could deliver this depth of personalisation to a few dozen families, because every synthesis was manual. The same standard can now hold across a full panel.
Physician experience supports this.
In the AMA’s six-country study on consumer wearables in clinical practice, physicians who integrated wearable data reported higher clinical advantage and stronger patient demand than those who had not.
The conditions matter
The same AMA data carries a warning. The physicians reporting good outcomes are the ones with interpretive confidence, trust in the data, and manageable workflow burden.
AI bolsters physicians under specific conditions. Outside those conditions it adds work without adding safety.
At Longevitix we build operational infrastructure for preventive medicine, and four conditions come up in every deployment.
The inputs have to be validated. Consumer sensors are reliable for resting heart rate and step count, weaker for blood pressure and SpO₂. The system has to know the error margin of every source before interpretation starts.
The data has to live in one place. A trend split across five apps is invisible to everyone. Preventive medicine fails without data unification, and any AI built on fragmented inputs fails with it.
The reasoning has to be auditable. When the system flags a finding, the physician needs to trace the line from raw data to flag.
A finding you cannot reconstruct is one you can neither act on nor safely dismiss.
And the physician decides. The platform surfaces patterns, evidence, and possible interventions. The decision and the accountability stay with the clinician.
Eyes open
The failure modes deserve naming.
Deskilling follows if physicians stop exercising the judgment these tools extend. My clinic sees chatbot output weekly that validates whatever the patient already believed, and the January regulatory change means more of it is coming.
The response to both is to keep physician reasoning at the centre and build the machinery around it.
My triathlete is back in training, euthyroid, and the system knows her baseline better than before.
She never noticed the second set of eyes on her data for fourteen months. She noticed that her physician caught what mattered.
About Dr Neil Panchal
Dr Neil Panchal is co-founder and chief medical officer of Longevitix, where he leads clinical strategy at the intersection of longevity medicine, evidence synthesis, and responsible AI.
A board-certified emergency physician trained at Mount Sinai (NYC) and Stanford Medicine with affiliations including Yale New Haven Health, he brings frontline clinical expertise and informatics leadership to healthcare delivery innovation and digital health transformation.
This unique blend of clinical expertise, technology leadership, and entrepreneurial execution positions him to contribute meaningfully to the future of healthcare.
